Compare METCI & GRMLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | METCI | GRMLW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2022 |
| Metric | METCI | GRMLW |
|---|---|---|
| Price | $25.01 | $0.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.5K | ★ 8.0K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.61 | $0.10 |
| 52 Week High | $26.20 | $0.17 |
| Indicator | METCI | GRMLW |
|---|---|---|
| Relative Strength Index (RSI) | 43.69 | 66.37 |
| Support Level | N/A | $0.10 |
| Resistance Level | $25.29 | $0.17 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 70.18 | 63.78 |
Greenland Mines Ltd operates in two divisions: (1) Natural Resources, focused on the exploration and development of the Skaergaard Project in Southeast Greenland, an undeveloped palladium, gold, and platinum deposit; and 2) Cell and Gene Therapy, which focuses on the development of biologic, cell, and gene therapies for neurodegenerative and age-related disorders, including Alzheimer's, amyotrophic lateral sclerosis (ALS), Parkinson's, and related conditions, targeting areas of high unmet medical need.